Printer Friendly

Punctaporonins N-S, New Caryophyllene Sesquiterpenoids from Cytospora sp.

1. Introduction

Fungi are capable of producing a variety of bioactive secondary metabolites [1]. Since the secondary metabolism of fungi may be influenced by selection pressures exerted by other organisms and the environment in which they reside, those species thriving in unique and competitive niches are especially likely to produce bioactive natural products with diverse and interesting structural features [2,3]. Based on this consideration and the documented success in finding new bioactive natural products from special types of fungi [4], we initiated chemical studies of the fungi inhabiting either the fruiting body and larvae of Cordyceps sinensis [5-10] or its surface soil [11-13]. As an extension, we also studied those species isolated from the soil samples that were collected on the Qinghai-Tibetan plateau at altitudes above 3,200 m, the environment in which Cordyceps sinensis was typically found. During the course of our continuing search for new bioactive natural products from this kind of fungal species, an ascomycetous fungus Cytospora sp. was isolated from a soil sample that was collected at Linzhi, Tibet, China. Our initial investigation of this fungus that was fermented in rice medium at 25[degrees]C led to the isolation of three antimicrobial caryophyllene-derivedmeroterpenoids [14,15] and three cytotoxic caryophyllene sesquiterpenoids [16]. In the current work, the fungus was refermented in the same solid culture medium at 15[degrees] C, and the HPLC chromatogram of the crude extract revealed the presence of additional components. Fractionation of an EtOAc extract afforded six new caryophyllene sesquiterpenoids, which we named punctaporonins N-S (1-6), and three known ones, 6-hydroxypunctaporonins B (7), A (8), and E (9) (Figure 1) [17]. Details of the isolation, structure elucidation, and cytotoxicity of these compounds are described herein.

2. Materials and Methods

2.1. General Experimental Procedures. Optical rotations were measured on a Perkin-Elmer 241 polarimeter, and UV data were recorded on a Shimadzu Biospec-1601 spectrophotometer. IR data were recorded using a Nicolet Magna-IR 750 spectrophotometer. [sup.1]H and [sup.13] C NMR data were acquired with Varian Mercury-400, Varian Mercury-500, and Varian Mercury-600 MHz spectrometers using solvent signals (acetone-[d.sub.6]: [[delta].sub.H] 2.05/SC 29.8,206.1; pyridine-[d.sub.5]: [[delta].sub.H] 7.21,7.58, 8.73) as references. The HMQC and HMBC experiments were optimized for 145.0 and 8.0 Hz, respectively. ESIMS data and HRESIMS data were obtained using an Agilent Accurate-Mass-Q-TOF LC/MS 6520 instrument equipped with an electrospray ionization (ESI) source. The fragmentor and capillary voltages were kept at 125 and 3500 V, respectively. Nitrogen was supplied as the nebulizing and drying gas (300[degrees]C). The flow rate of the drying gas and the pressure of the nebulizer were 10 L/min and 10 psi, respectively. All MS experiments were performed in positive ion mode. Full-scan spectra were acquired over a scan range of m/z 100-1000 at 1.03 spectra/s. All solvents used were of analytical grade. Column chromatography was performed with silica gel (100-200 or 200-300 mesh, Qingdao Marine Chemical Inc., China) and Sephadex LH-20 (GE, USA). Semipreparative HPLC was performed on an Agilent 1260 G1311C isopump equipped with a G1365D MWD detector and an Agilent Zorbax SB-[C.sub.18] column (5 [micro]m; 9.40 mm x 250 mm).

2.2. Fungal Material and Fermentation. The isolation, identification, and fermentation of the fungus Cytospora sp. were the same as those we previously described [14-16], except the incubation temperature was changed to 15[degrees]C.

2.3. Extraction and Isolation. The fermented material was extracted with EtOAc (4 x 1.0 L), and the organic solvent was evaporated to dryness under vacuum to afford a crude extract (4.2 g). The extract was fractionated by silica gel VLC using petroleum ether-EtOAc gradient elution. The fraction (100 mg) eluted with 35% EtOAc was separated by Sephadex LH-20 column chromatography (CC) eluting with 1:1 C[H.sub.2][Cl.sub.2]-MeOH. The resulting subfractions were combined and further purified by semipreparative RP HPLC (59% MeOH in [H.sub.2]O for 35min; 2mL/min) to afford punctaporonins N (1; 4.5 mg, [t.sub.R] 21.22 min), O (2; 3.5 mg, [t.sub.R] 31.33 min), P (3; 2.0 mg, [t.sub.R] 14.05 min), and R (5; 0.8 mg, [t.sub.R] 24.22 min). The fraction (50 mg) eluted from the silica gel column with 45% EtOAc was purified by RP HPLC (35% C[H.sub.3]CN in [H.sub.2]O for 20 min; 2mL/min) to afford punctaporonin Q (4; 5.0 mg; [t.sub.R] 16.44 min). The fraction (35 mg) eluted from the silica gel column with 40% EtOAc was purified by RP HPLC (40% C[H.sub.3]CN in [H.sub.2]O for 20 min; 2mL/min) to afford punctaporonin S (6; 2.0 mg; [t.sub.R] 17.02 min). The fraction (150 mg) eluted from the silica gel column with 50% EtOAc was fractionated again by Sephadex LH-20 CC eluting with 1:1 C[H.sub.2][Cl.sub.2]-MeOH. Purification of the resulting subfractions with different gradients afforded 6-hydroxypunctaporonins B (7; 10.0 mg, [t.sub.R] 23.61 min; 50% MeOH in [H.sub.2]O for 30 min), A (8; 8.4 mg, [t.sub.R] 16.12 min; same gradient as in purification of 7), and E (9; 3.5 mg, [t.sub.R] 14.83 min; same gradient as in purification of 7).

2.4. Identification

Punctaporonin N (1). White powder (MeOH); [[[alpha]].sup.25.sub.D] -73 (c 0.1, MeOH); UV (MeOH) [[lambda].sub.max] (log [epsilon]) 198 (3.40) nm; IR (neat) [v.sub.max] 3317 (br), 2936, 2870,1736,1714,1463,1372,1241, 1095,1037 [cm.sup.-1]; [sup.1]H, [sup.13]C NMR, HMBC, and NOESY data see Table 1; (+)-HR-ESI-MS m/z 305.1719 [[M + Na].sup.+] (calcd. for [C.sub.16][H.sub.26][O.sub.4]Na, 305.1723).

Punctaporonin O (2). Colorless oil (MeOH); [[[alpha]].sup.25.sub.D] -47 (c 0.1, MeOH); UV (MeOH) [[lambda].sub.max] (log [epsilon]) 202 (3.58) nm; IR (neat) [v.sub.max] 3263 (br), 2932, 2875, 1713, 1463, 1361, 1181, 1089, 1058, 1029 [cm.sup.-1]; [sup.1]H and [sup.13]C NMR data see Table 2; (+)-HR-ESI-MS m/z 305.1721 [[M + Na].sup.+] (calcd. for [C.sub.16][H.sub.26][O.sub.4]Na, 305.1723).

Punctaporonin P (3). Colorless oil (MeOH); [[[alpha]].sup.25.sub.D] -71 (c 0.1, MeOH); UV (MeOH) [[lambda].sub.max] (log [epsilon]) 203 (3.55) nm; IR (neat) [v.sub.max] 3262 (br), 2958, 2935, 2872, 1735, 1717, 1372, 1240, 1089, 1021[cm.sup.-1]; [sup.1]H and [sup.13]C NMR data see Table 2; (+)-HR-ESI-MS m/z 333.1669 [[M + Na].sup.+] (calcd. for [C.sub.17][H.sub.26][O.sub.5]Na, 333.1672).

Punctaporonin Q (4). Colorless oil (MeOH); [[[alpha]].sup.25.sub.D] -37 (c 0.1, MeOH); UV (MeOH) [[lambda].sub.max] (log [epsilon]) 203 (3.60) nm; IR (neat) [v.sub.max] 3438 (br), 2957, 2936, 1730, 1715, 1381, 1249, 1031 [cm.sup.- 1];[sup.1]H and [sup.13]C NMR data see Table 2; (+)-HR-ESI-MS m/z 333.1676 [[M + Na].sup.+] (calcd. for [C.sub.17][H.sub.26][O.sub.5]Na, 333.1672).

Punctaporonin R (5). Colorless oil (MeOH); [[[alpha]].sup.25.sub.D] -30 (c 0.1, MeOH); UV (MeOH) [[lambda].sub.max] (log [epsilon]) 200 (3.22) nm; IR (neat) [v.sub.max] 3256 (br), 2957, 2934, 2869, 1711, 1462, 1365, 1102, 1057, 1031, 984 [cm.sup.-1]; [sup.1]H and [sup.13]C NMR data see Table 3; (+)-HR-ESI-MS m/z 305.1717 [[M + Na].sup.+] (calcd. for [C.sub.16][H.sub.26][O.sub.4]Na, 305.1723).

Punctaporonin S (6). Colorless oil (MeOH); [[[alpha]].sup.25.sub.D] -84 (c 0.1, MeOH); UV (MeOH) [[lambda].sub.max] (log [epsilon]) 202 (3.56) nm; IR (neat) [v.sub.max] 3486 (br), 2953, 2938, 2871, 1736, 1374, 1252, 1040, 990 [cm.sup.-1]; [sup.1]H and [sup.13]C NMR data see Table 3; (+)-HR-ESI-MS m/z 375.1781 [[M + Na].sup.+] (calcd. for [C.sub.19][H.sub.28][O.sub.6]Na, 375.1778).

6-Hydroxypunctaporonin B (7). [sup.1]H, [sup.13]C NMR, and the MS data were consistent with literature values [17].

6-Hydroxypunctaporonin A (8). [sup.1]H, [sup.13]C NMR, and the MS data were consistent with literature values [17].

6-Hydroxypunctaporonin E (9). [sup.1]H, [sup.13]C NMR, and the MS data were consistent with literature values [17].

2.5. Preparation of (S)-MTPA Ester (1a). A sample of 1 (2.0 mg, 0.007 mmol) was dissolved in pyridine (2.0 mL) in a 10 mL round-bottomed flask. (R)-MTPA Cl (2.0 [micro]L, 0.011 mmol) were quickly added, and the flask was sealed and all contents were stirred at room temperature for 12 h. The mixture was evaporated to dryness and purified by semipreparative HPLC (90% C[H.sub.3]OH in [H.sub.2]O for 20min; 2mL/min) to afford 1a (2.2 mg, [t.sub.R] 15.72 min): colorless platelets; [sup.1]H NMR (pyridine-d5, 500 MHz) 5 6.16 (1H, s, H11), 6.00 (1H, d, J = 13 Hz, H-9), 5.75 (1H, d, J = 13 Hz, H-10), 5.55 (1H, d, J = 12 Hz, H-12a), 5.46 (1H, d, J = 12 Hz, H-12b), 4.37 (1H, s, H-6), 3.35 (3H, s, [H.sub.3]-16), 3.09 (1H, d, J = 10 Hz, H-2), 2.34 (1H, t, J = 10 Hz, H-3a), 2.11 (1H, d, J = 16 Hz, H-7a), 1.54 (1H, t, J = 10 Hz, H-3b), 1.35 (1H, d, J = 16 Hz, H-7b), 1.37 (3H, s, [H.sub.3]-13), 1.37 (3H, s, [H.sub.3]-14), 1.18 (3H, s, [H.sub.3]-15).

2.6. X-Ray Crystallographic Analysis of 1a [18]. Upon crystallization from MeOH/[H.sub.2]O (10: 1) using the vapor diffusion method, colorless crystals were obtained for 1a, and a crystal (0.90 x 0.27 x 0.08 [mm.sup.3]) was separated from the sample and mounted on a glass fiber, and data were collected using a Rigaku Saturn CCD area detector with graphitemonochromated Mo Ka radiation, [lambda] = 0.71073 [Angstrom]] at 173(2) K. Crystal data: [C.sub.26][H.sub.33][F.sub.3][O.sub.6]*[H.sub.2]O, M = 516.54, space group orthorhombic, P212121; unit cell dimensions a = 6.9639 (14) [Angstrom], b = 17.211 (3) [Angstrom], c = 21.948 (5) [Angstrom], V = 2630.5 (9) [[Angstrom].sup.3], Z = 4, [D.sub.calcd] = 1.304 mg/[m.sup.3], [mu] = 0.107 [mm.sup.-1], F(000) = 1096. The structure was solved by direct methods using SHELXL-2016 [19] and refined using full-matrix least-squares difference Fourier techniques. All nonhydrogen atoms were refined with anisotropic displacement parameters, and all hydrogen atoms were placed in idealized positions and refined as riding atoms with the relative isotropic parameters. Absorption corrections were applied with the Siemens Area Detector Absorption Program (SADABS) [20]. The 14274 measurements yielded 4799 independent reflections after equivalent data were averaged, and Lorentz and polarization corrections were applied. The final refinement gave [R.sub.1] = 0.0811 and [R.sub.2] = 0.1232 [I > 2[sigma](7)].

2.7. MTS Assay. The MTS assay method was the same as that we previously described [16, 21, 22].

3. Results and Discussion

Punctaporonin N (1) was obtained as a white powder with a molecular formula of [C.sub.16][H.sub.26][O.sub.4] (four degrees of unsaturation), established by HRESIMS. Analysis of its NMR spectroscopic data (Table 1) revealed structural similarity to the coisolated known compound 6-hydroxypunctaporonin B (7) [17], except for the presence of an O-methyl group ([delta].sub.H]/[[delta].sub.C] 3.26/48.7) attached to C-8, rather than a free hydroxy group as found in 7. This observation was supported by an HMBC correlation from the O-methyl proton signal ([H.sub.3]-16) to the oxygenated sp3 quaternary carbon at 78.4 ppm (C-8). Therefore, 1 was proposed as the C-8 methyl ether of 7.

The relative configuration of 1 was determined by analysis of the [sup.1]H-[sup.1]H coupling constants and NOESY data (Figure 2). The coupling constant of 13.0 Hz between H-9 and H-10, which was exactly the same as in 7, suggested the Z-geometry for the C-9/C-10 olefin [17]. The C-1/C-11 olefin was deduced to be E-configuration based on NOESY correlation of H-11 with H-12b. NOESY correlations of -13 with H-2, H-3b, and H-6 and H-6 with [H.sub.3]-16 indicated that these protons are all on the same face of the ring system, whereas that of [H.sub.3]- 14 with OH-5 was used to place them on the opposite face, thereby establishing the relative configuration of 1.

The modified Mosher method was tried to apply assigning the C-6 absolute configuration of 1. However, treatment of 1 with (R) or (S)-MTPA Cl to form the C-6 MTPA ester was unsuccessful; instead the reaction products C-12 S-MTPA ester (1a) and C-12 R- MTPA ester (1b) were generated. In order to establish the absolute configuration of 1, one of the reaction products C-12 S-MTPA ester (1a) was purified by HPLC to obtain a single crystal, and its perspective ORTEP plot is shown in Figure 3. Although the X-ray diffraction was collected by Mo Ka radiation, which only gave the relative configuration for 1a, the absolute configuration of the chiral center at C-18 generated from (R)-MTPA Cl had been assigned to be S. Therefore, the absolute configuration of 1 was established as 2R, 5S, 6S, and 8S by single-crystal X-ray crystallographic analysis of its C-12 S-MTPA ester (1a).

Punctaporonin O (2) was assigned the same molecular formula [C.sub.16][H.sub.26][O.sub.4] as 1 by HRESIMS. Its NMR data (Table 2) were nearly identical to those of the coisolated known compound 6-hydroxypunctaporonin A (8) [17], except that the exchangeable proton at 4.18 ppm (OH-9) was replaced by a methyl group ([[delta].sub.H]/[[delta].sub.C] 3.33/57.5). An HMBC correlation from the O-methyl proton signal ([H.sub.3]-16) to the oxymethine carbon at 97.3 ppm (C-9) suggested that 2 is the C-9 methyl ether of 8. The absolute configuration of 2 was proposed as shown by analogy to 8, which was also supported by the nearly identical specific rotation values recorded for both compounds [17].

The molecular formula of punctaporonin P (3) was determined to be [C.sub.17][H.sub.26][O.sub.5] (five degrees of unsaturation) by HRESIMS, which is 28 mass units more than that of 2, corresponding to an extra carbonyl group. The NMR data of 3 (Table 2) were similar to those of 2, except that the oxymethine proton at 3.60 ppm (H-9) was significantly downfield to 5.11 ppm in 3. In addition, the O-methyl group attached to C-9 was replaced by an acetyl unit ([[delta].sub.H]/[[delta].sub.C] 2.03/21.3, 170.4), indicating that the C-9 oxygen of 3 was acetylated. An HMBC correlation from the downfield oxymethine proton (H-9) to the carboxylic carbon at 170.4 ppm indicated that 3 is the C-9 monoacetate of 8, with its configuration similarly deduced by analogy to compounds 1 and 2.

Punctaporonin Q (4) gave a pseudomolecular ion [[M + Na].sup.+] peak by HRESIMS, consistent with the molecular formula [C.sub.17][H.sub.26][O.sub.5] (five degrees of unsaturation), which is the same as 3. Its NMR spectra showed resonances similar to those of 3, indicating that 4 is also a monoacetate of 8, but with a different position for acetylation. Specifically, the [sup.1]H NMR chemical shifts of [H.sub.2]-12 in 4 ([[delta].sub.H] 4.37 and 4.57, Table 2) were significantly downfield compared to those in 3 ([[delta].sub.H] 3.48 and 3.73), suggesting that OH-12 was acetylated. The observation was supported by an HMBC correlation from [H.sub.2]-12 to the carboxylic carbon of the acetyl unit ([[delta].sub.C] 171.0).

The elemental composition of punctaporonin R (5) was established as [C.sub.16][H.sub.26][O.sub.4] (four degrees of unsaturation) by HRESIMS, which has one more C[H.sub.2] unit than another coisolated known compound, 6-hydroxypunctaporonin E (9) [17]. Comparison of the NMR data of 5 (Table 3) and 9 readily identified 5 as the C-11 methyl ether ([[delta].sub.H]/ [[delta].sub.C] 3.19/60.7) of the latter and having the same configuration as its precedent.

Punctaporonin S (6) was assigned the molecular formula [C.sub.19][H.sub.28][O.sub.6] (six degrees of unsaturation) by HRESIMS. Its NMR spectra showed structural characteristics similar to those of 5, but the [sup.1]H NMR chemical shifts of H-11 ([[delta].sub.H] 5.70) and [H.sub.2]-12 ([[delta].sub.H] 4.06 and 4.88) were significantly downfield compared to 5 (H-11: [[delta].sub.H] 3.62; [H.sub.2]-12: [[delta].sub.H] 3.65 and 4.06), indicating that both OH-11 and OH-12 are acetylated, which were supported by relevant HMBC correlations. Therefore, 6 was assigned as the diacetate of the known compound 9, with its configuration deduced as shown.

To verify that the new metabolites 1-6 are authentic natural products, a portion of the freeze-dried fermented rice substrate was extracted with distilled, HPLC grade acetone, and the resulting extract was subjected to RP HPLC analysis using distilled, HPLC grade [H.sub.2]O and MeOH as solvents. Compounds 1-6 were identified on the HPLC chromatogram of the crude extract by comparison of their retention times with the pure compounds, indicating that 1-6 are indeed naturally occurring metabolites.

Compounds 2, 5, and 6 showed modest cytotoxicity against HeLa (cervical epithelium) cells, showing [IC.sub.50] values of 16.6,10.4, and 47.4 [micro]M, respectively, while the positive control cisplatin showed an [IC.sub.50] value of 7.6 [micro]M. The remaining compounds did not show noticeable cytotoxic effects against HeLa cells ([IC.sub.50] > 100 [micro]M).

4. Conclusion

In summary, six new caryophyllene sesquiterpenoids, punctaporonins N-S (1-6), and three known ones, 6-hydroxypunctaporonins B (7), A (8), and E (9), have been isolated from solid cultures of Cytospora sp. The structures of 1-6 were elucidated primarily by NMR spectroscopy. The absolute configuration of 1 was assigned by X-ray crystallographic analysis of its S-MTPA ester. Compounds 2, 5, and 6 showed modest cytotoxicity against HeLa cells. These results implied that the fungi isolated from those unique and competitive niches could prove to be valuable sources of new bioactive natural products.

https://doi.org/10.1155/2017/7871459

Conflicts of Interest

The authors have declared that there are no conflicts of interest.

Acknowledgments

The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (81202416).

References

[1] T. Henkel, R. M. Brunne, H. Muller, and F. Reichel, "Statistical investigation into the structural complementarity of natural products and synthetic compounds," Angewandte Chemie International Edition, vol. 38, no. 5, pp. 643-647,1999.

[2] J. B. Gloer, "Antiinsectan Natural Products from Fungal Sclerotia," Accounts of Chemical Research, vol. 28, no. 8, pp. 343-350, 1995.

[3] J. Meinwald and T. Eisner, "Chemical ecology in retrospect and prospect," Proceedings of the National Acadamy of Sciences of the United States of America, vol. 105, no. 12, pp. 4539-4540, 2008.

[4] J. B. Gloer, "The mycota. A comprehensive treatise on fungi as experimental systems for basic applied research. Volume IV: environmental and microbial relationships," in The Mycota IV: Environmental and Microbial Relationships, D. T. Wicklow and B. Soderstrom, Eds., pp. 249-268, Springer, Berlin, Germany, 1997.

[5] H. Guo, H. Hu, S. Liu, X. Liu, Y. Zhou, and Y. Che, "Bioactive p-terphenyl derivatives from a Cordyceps-colonizing isolate of Gliocladium sp," Journal of Natural Products, vol. 70, no. 9, pp. 1519-1521, 2007.

[6] Y. Zhang, S. Liu, Y. Che, and X. Liu, "Epicoccins A-D, epipolythiodioxopiperazines from a Cordyceps-colonizing isolate of Epicoccum nigrum " Journal of Natural Products, vol. 70, no. 9, pp. 1522-1525, 2007.

[7] H. Guo, B. Sun, H. Gao et al., "Trichocladinols A-C, cytotoxic metabolites from a Covdyceps-colomzing ascomycete Trichocladium opacum," European Journal of Organic Chemistry, no. 32, pp. 5525-5530, 2009.

[8] Y. Zhang, S. Liu, H. Liu, X. Liu, and Y. Che, "Cycloaspeptides F and G, cyclic pentapeptides from a Cordyceps-colonizing isolate of Isaria farinosa," Journal of Natural Products, vol. 72, no. 7, pp. 1364-1367, 2009.

[9] Y. Chen, H. Guo, Z. Du, X.-Z. Liu, Y. Che, and X. Ye, "Ecology-based screen identifies new metabolites from a Cordycepscolonizing fungus as cancer cell proliferation inhibitors and apoptosis inducers," Cell Proliferation, vol. 42, no. 6, pp. 838-847, 2009.

[10] C. Ma, Y. Li, S.-B. Niu, H. Zhang, X.-Z. Liu, and Y. Che, "N-hydroxypyridones, phenylhydrazones, and a quinazolinone from isaria farinosa," Journal of Natural Products, vol. 74, no. 1, pp. 32-37, 2011.

[11] J. Lin, S. Liu, B. Sun et al., "Polyketides from the ascomycete fungus Leptosphaeria sp.," Journal of Natural Products, vol. 73, no. 5, pp. 905-910, 2010.

[12] X. Zou, S. Niu, J. Ren, E. Li, X. Liu, and Y. Che, "Verrucamides AD, antibacterial cyclopeptides from Myrothecium verrucaria," Journal of Natural Products, vol. 74, no. 5, pp. 1111-1116, 2011.

[13] J. Lin, X. Chen, X. Cai et al., "Isolation and characterization of aphidicolin and chlamydosporol derivatives from Tolypocladium inflatum," Journal of Natural Products, vol. 74, no. 8, pp. 1798-1804, 2011.

[14] Y. Li, S. Niu, B. Sun, S. Liu, X. Liu, and Y. Che, "Cytosporolides A-C, antimicrobial meroterpenoids with a unique peroxylactone skeleton from cytospora sp.," Organic Letters, vol. 12, no. 14, pp. 3144-3147, 2010.

[15] J. T. J. Spence and J. H. George, "Structural reassignment of cytosporolides A-C via Biomimetic synthetic studies and reinterpretation of NMR Data," Organic Letters, vol. 13, no. 19, pp. 5318-5321, 2011.

[16] Y. Li, C. Li, C. Cui, X. Liu, and Y. Che, "Cytosporinols A-C, new caryophyllene sesquiterpenoids from Cytospora sp.," Natural Products and Bioprospecting, vol. 2, no. 2, pp. 70-75, 2012.

[17] S. T. Deyrup, D. C. Swenson, J. B. Gloer, and D. T. Wicklow, "Caryophyllene sesquiterpenoids from a fungicolous isolate of Pestalotiopsis disseminata," Journal of Natural Products, vol. 69, no. 4, pp. 608-611, 2006.

[18] Crystallographic data for compound 1a have been deposited with the Cambridge Crystallographic Data Centre (deposition number CCDC 778343). Copies of the data can be obtained, free of charge, on application to the director, CCDC 12 Union Road, Cambridge CB2 1EZ, UK, 2017.

[19] Sheldrick G. M., "Crystal structure refinement with SHELXL," Acta Crystallographica, vol. C71, pp. 3-8, 2015.

[20] G. M. Sheldrick, SADABS, program for empirical absorption correction of area detectordata, University of Gottingen, Gottingen, Germany, 1999.

[21] Y. Li, D. Ye, Z. Shao, C. Cui, and Y. Che, "A sterol and spiroditerpenoids from a Penicillium sp. isolated from a deep sea sediment sample," Marine Drugs, vol. 10, no. 2, pp. 497-508, 2012.

[22] N. Zhang, Y. Chen, R. Jiang et al., "PARP and RIP-1 are required for autophagy induced by 11/- deoxyverticillin A, which precedes caspase-dependent apoptosis," Autophagy, vol. 7, no. 6, pp. 598-612, 2011.

Yan Li, (1,2) Qingbin Wang, (1) Xingzhong Liu, (3) and Yongsheng Che (1)

(1) State Key Laboratory of Toxicology & Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, China

(2) Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Beijing 100081, China

(3) State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100190, China

Correspondence should be addressed to Yongsheng Che; cheys@im.ac.cn

Received 5 May 2017; Revised 27 July 2017; Accepted 22 August 2017; Published 24 October 2017

Academic Editor: Jane Hanrahan

Caption: FIGURE 1: Structures of compounds 1-9.

Caption: FIGURE 2: Key NOESY correlations for punctaporonin N (1).

Caption: FIGURE 3: Thermal ellipsoid representation of 1a.
TABLE 1: NMR data (400 MHz, Acetone-[d.sub.6])
for punctaporonin N (1).

Position    [[delta].sub.C],     [[delta].sub.H]
                 mult.              (J in Hz)

1              140.0, qC
2               39.8, CH       3.39, dd (11.9, 8.2)
3a          34.0, [CH.sub.2]   2.15, dd (11.9, 9.8)
3b                             1.49, dd (9.8, 8.2)
4               41.0, qC
5               82.7, qC
6               71.4, CH         3.86, br d (4.7)
7a          42.5, [CH.sub.2]   2.63, dd (16.3, 4.7)
7b                             1.64, dt (16.3, 2.0)
8               78.4, qC
9              141.9, CH       5.70, dt (13.0, 2.0)
10             124.5, CH          5.62, d (13.0)
11             125.9, CH             5.88, s
12a         64.8, [CH.sub.2]      4.19, d (12.0)
12b                               3.93, d (12.0)
13             24.6, CH3             1.23, s
14             24.1, CH3             1.07, s
15             26.0, CH3             1.10, s
16             48.7, CH3             3.26, s
OH-5                                4.53, br s
OH-6                                4.67, br s
OH-12                               3.14, br s

Position       HMBC (a)           NOESY

1
2           1, 3, 5, 11, 12        13
3a          1, 2, 4, 13, 14
3b            2, 4, 5, 13          13
4
5
6                                13, 16
7a             5, 6, 15
7b            6, 8, 9, 15
8
9              7, 10, 11
10               1, 9
11            1, 2, 9, 12          12b
12a              1, 11
12b            1, 2, 11          11, 13
13            3, 4, 5, 14     2, 3b, 6, 12b
14            3, 4, 5, 13         OH-5
15              7, 8, 9            16
16                 8              6, 15
OH-5                               14
OH-6
OH-12

(a) HMBC correlations, optimized for 8 Hz, are from proton(s)
stated to the indicated carbon.

TABLE 2: NMR spectroscopic data for punctaporonins
O-Q (2-4) in acetone-[d.sub.6].

                             2

Position    [[delta].sub.C]       [[delta].sub.H]
               (a), mult.          (b) (J in Hz)

1               55.3, qC
2               47.1, CH       2.54, dd (13.0, 8.0)
3a          35.5, [CH.sub.2]   2.02, dd (13.0, 8.0)
3b                                 1.46, t (8.0)
4               42.8, qC
5               80.6, qC
6               68.9, CH       4.09, dd (10.0, 5.6)
7a          41.5, [CH.sub.2]   1.86, dd (13.5, 5.6)
7b                             1.56, dd (13.5, 10.0)
8               51.0, qC
9               97.3, CH           3.60, d (2.0)
10             127.9, CH        5.90, dd (6.0, 2.0)
11             143.4, CH           5.74, d (6.0)
12a         62.2, [CH.sub.2]      3.68, d (11.4)
12b                               3.40, d (11.4)
13          23.4, [CH.sub.3]          1.11, s
14          24.1, [CH.sub.3]          1.08, s
15          24.6, [CH.sub.3]          1.05, s
16          57.5, [CH.sub.3]          3.33, s
OH-5                                4.82, br s
OH-6                                5.39, br s
OH-9
OH-12                               3.25, br s
Ac-9
Ac-12

                             3

Position    [[delta].sub.C]         [[delta].sub.H]
               (a), mult.            (b) (J in Hz)

1               55.6, qC
2               47.2, CH          2.32, dd (12.8, 7.8)
3a          35.5, [CH.sub.2]      2.08, dd (12.8, 8.9)
3b                                1.52, dd (8.9, 7.8)
4               42.9, qC
5               80.4, qC
6               68.7, CH       4.06, ddd (10.3, 7.9, 5.6)
7a          41.2, [CH.sub.2]      1.77, dd (14.0, 5.6)
7b                               1.62, dd (14.0, 10.3)
8               50.0, qC
9               89.4, CH             5.11, d (2.5)
10             126.6, CH          5.67, dd (5.9, 2.5)
11             145.3, CH             5.88, d (5.9)
12a         62.0, [CH.sub.2]         3.73, d (11.2)
12b                               3.48, dd (11.2, 8.0)
13          23.4, [CH.sub.3]            1.19, s
14          24.0, [CH.sub.3]            1.12, s
15          24.3, [CH.sub.3]            1.10, s
16
OH-5                                    4.88, s
OH-6                                 5.37, d (7.9)
OH-9
OH-12                                3.44, d (8.0)
Ac-9        21.3, [CH.sub.3]            2.03, s
               170.4, qC
Ac-12

                             4

Position    [[delta].sub.C]       [[delta].sub.H]
               (a), mult.          (b) (J in Hz)

1               53.6, qC
2               45.6, CH       2.35, dd (12.5, 7.9)
3a          36.3, [CH.sub.2]   2.13, dd (12.5, 9.2)
3b                              1.46, dd (9.2, 7.9)
4               42.7, qC
5               81.7, qC
6               68.9, CH       4.17, dd (10.0, 5.9)
7a          40.3, [CH.sub.2]   1.90, dd (13.5, 5.9)
7b                             1.64, dd (13.5, 10.0)
8               50.9, qC
9               86.5, CH           4.07, d (2.5)
10             130.6, CH        5.68, dd (6.0, 2.5)
11             141.2, CH           5.92, d (6.0)
12a         65.6, [CH.sub.2]      4.57, d (11.6)
12b                               4.37, d (11.6)
13          23.3, [CH.sub.3]          1.10, s
14          23.7, [CH.sub.3]          1.05, s
15          26.2, [CH.sub.3]          0.84, s
16
OH-5
OH-6
OH-9                                  3.29, s
OH-12
Ac-9
Ac-12       21.0, [CH.sub.3]          1.93, s
               171.0, qC

(a) Recorded at 100 MHz. (b) Recorded at 500 MHz.

TABLE 3: NMR spectroscopic data for punctaporonins
R (5) and S (6) in acetone-d6.

                             5

Position    [[delta].sub.C]      [[delta].sub.C]
               (a), mult.         (b) (J in Hz)

1               51.2, qC
2               43.8, CH          2.09, t (7.3)
3a          35.8, [CH.sub.2]   2.02, dd (7.3, 5.5)
3b                                1.54, t (5.5)
4               42.1, qC
5               80.2, qC
6               69.3, CH       3.47, dd (11.3,7.3)
7a          42.9, [CH.sub.2]      1.71, d (11.3)
7b
8               53.6, qC
9              149.2, CH          5.85, d (5.8)
10             126.8, CH       5.82, dd (5.8, 2.2)
11              90.9, CH          3.62, d (2.2)
12a         57.3, [CH.sub.2]      3.65, d (11.4)
12b                            4.06, dd (11.4, 7.0)
13          23.3, [CH.sub.3]         1.10, s
14          24.2, [CH.sub.3]         1.08, s
15          27.3, [CH.sub.3]         1.18, s
16          60.7, [CH.sub.3]         3.19, s
OH-5                                5.29, br s
OH-6                              5.18, d (7.3)
OH-12                             3.09, d (7.0)
Ac-11
Ac-12

                                       6

Position         [[delta].sub.C]              [[delta].sub.C]
                    (c), mult.                 (b) (J in Hz)

1                    53.6, qC
2                    39.2, CH            2.01, ddd (12.4, 7.8,1.4)
3a               37.8, [CH.sub.2]          2.37, dd (12.4, 9.2)
3b                                          1.73, dd (9.2, 7.8)
4                    42.2, qC
5                    82.6, qC
6                    69.0, CH              3.66, dd (10.2, 5.5)
7a               42.4, [CH.sub.2]          1.94, dd (12.2, 5.5)
7b                                         1.86, dd (12.2, 10.2)
8                    48.8, qC
9                   150.0, CH                  6.01, d (5.7)
10                  126.8, CH               5.70, dd (5.7, 2.7)
11                   81.3, CH                  5.28, d (2.7)
12a              63.6, [CH.sub.2]              4.88 d (10.2)
12b                                        4.06, dd (10.2, 1.4)
13               22.9, [CH.sub.3]                 1.14, s
14               23.6, [CH.sub.3]                 1.10, s
15               27.9, [CH.sub.3]                 1.11, s
16
OH-5
OH-6                                            3.69, (5.5)
OH-12
Ac-11       20.8, [CH.sub.3] 170.1, qC            1.93, s
Ac-12       21.0, [CH.sub.3] 170.9, qC            1.95, s

(a) Recorded at 150 MHz. (b) Recorded at 500 MHz.
(c) Recorded at 100 MHz.
COPYRIGHT 2017 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Li, Yan; Wang, Qingbin; Liu, Xingzhong; Che, Yongsheng
Publication:BioMed Research International
Article Type:Report
Date:Jan 1, 2017
Words:5374
Previous Article:Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
Next Article:Practice and Barriers towards Provision of Health Promotion Services among Community Pharmacists in Gondar, Northwest Ethiopia.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters